UTICAJ NAČINA PRIMJENE NEUROLEPTIKA ORALNO ILI PARENTERALNO, NA INDEKS TJELESNE MASE KOD OBOLJELIH OD SHIZOFRENIJE. (Serbian)
In: Timocki Medicinski Glasnik, Jg. 40 (2015-10-01), Heft 4, S. 243-247
academicJournal
Zugriff:
Introduction: In the treatment of schizophrenia, neuroleptics play a significant role. Their use in a long period of time can lead to obesity. Aim: The objective was to compare the body mass index (BMI) in two groups of schizophrenic patients; a group treated with depot preparations neuroleptics and a group on oral neuroleptics. Patients and Methods: The study included 64 patients 18 to 65 years of age, who were divided into two groups: a group of patients treated with depot neuroleptics (fluphenazine, haloperidol, risperidone), and the control group, patients on depot neuroleptics, as per os therapy (fluphenazine, haloperidol, risperidone,). The following was analyzed: medical history, socio-demographic data, blood pressure, body weight, body height, BMI. Results: The average age of the respondents was 44.19 ± 7.785 (experimental group: 43.31 ± 6.879 and 45.06 ± control 8617). T-test for independent samples were compared to the results of body weight (kg), body height (cm), the experimental and control groups, and it was observed that there were no statistically significant disparities. There were no statistically significant differences of BMI between the groups Hi = 0000, p<0.05. Conclusion: On the basis of the research it can be concluded that there is no statistically significant difference in BMI in patients suffering from schizophrenia, regardless of whether they are treated with depot neuroleptics or per os neuroleptic therapy. [ABSTRACT FROM AUTHOR]
Uvod: U liječenju shizofrenije neuroleptici igraju značajnu ulogu. Njihova upotreba u dužem vremenskom periodu može dovesti do gojaznosti. Cilj istraživanja: Cilj istraživanja je bio da se uporedi indeks tjelesne mase (BMI) kod dve grupe shizofrenih pacijenata; grupa liječena depo preparatima neuroleptika i grupa na peroralnim neurolepticima. Ispitanici i metode: Ispitivanjem je obuhvaćeno 64 pacijenta starosti od 18 do 65 god. koji su podijeljeni u dvije grupe: grupu pacijenata liječenih depo preparatima neuroleptika (flufenazin, haloperidol, risperidon), i kontrolnu grupu, pacijenti koji su uzimali per os terapiju (flufenazin, haloperidol, risperidon). Analizirani su: anamnestički podaci, sociodemografski podaci, arterijski krvni pritisak, tjelesna težina, tjelesna visina, i BMI. Rezultati: Prosječna starost svih ispitanika je bila 44,19±7,785 godina (eksperimentalna grupa: 43,31±6,879 i kontrolna 45,06±8,617 godina). T-testom nezavisnih uzoraka upoređeni su rezultati tjelesne težine (kg), tjelesne visine (cm) ispitanika eksperimentalne i kontrolne grupe i uočeno je da nema statistički značajne razlike. Nije bilo statistički značajne razlike u BMI između ispitivanih grupa, Hi=0000, p>0,05. Zaključak: Na osnovu sprovedenog istraživanja, može se zaključiti da nema statistički značajne razlike u BMI kod pacijenata koji boluju od shizofrenije, bez obzira da li se liječe depo preparatima neuroleptka ili neuroleptike uzimaju per os. [ABSTRACT FROM AUTHOR]
Copyright of Timocki Medicinski Glasnik is the property of Timocki Medicinski Glasnik and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
UTICAJ NAČINA PRIMJENE NEUROLEPTIKA ORALNO ILI PARENTERALNO, NA INDEKS TJELESNE MASE KOD OBOLJELIH OD SHIZOFRENIJE. (Serbian)
|
---|---|
Autor/in / Beteiligte Person: | Simić Medojević, Ivana ; Burgić Radmanović, Marija |
Zeitschrift: | Timocki Medicinski Glasnik, Jg. 40 (2015-10-01), Heft 4, S. 243-247 |
Veröffentlichung: | 2015 |
Medientyp: | academicJournal |
ISSN: | 0350-2899 (print) |
Sonstiges: |
|